Enzymatica publ AB (ENZY) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.085x

Based on the latest financial reports, Enzymatica publ AB (ENZY) has a cash flow conversion efficiency ratio of -0.085x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-11.57 Million ≈ $-1.24 Million USD) by net assets (Skr135.68 Million ≈ $14.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Enzymatica publ AB for the company's overall valuation and market capitalisation.

Enzymatica publ AB - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how Enzymatica publ AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Enzymatica publ AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Enzymatica publ AB ranked by their cash flow conversion efficiency. Explore ENZY cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
PENTIXAPHARM HOLDING N AG XETRA:PTP	N/A
Health In Tech, Inc. Class A Common Stock NASDAQ:HIT	-0.154x
Werewolf Therapeutics Inc NASDAQ:HOWL	0.407x
Pancontinental Energy NL AU:PCL	-0.064x
Shuang-Bang Industrial TWO:6506	0.035x
Toro Energy Ltd AU:TOE	-0.245x
Vishnu Prakash R Punglia Limited NSE:VPRPL	0.089x
Ram-On Investments and Holdings Ltd TA:RMN	-0.001x

Annual Cash Flow Conversion Efficiency for Enzymatica publ AB (2009–2024)

The table below shows the annual cash flow conversion efficiency of Enzymatica publ AB from 2009 to 2024. View latest Enzymatica publ AB stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr176.37 Million ≈ $18.98 Million	Skr-60.51 Million ≈ $-6.51 Million	-0.343x	+34.76%
2023-12-31	Skr76.61 Million ≈ $8.24 Million	Skr-40.29 Million ≈ $-4.34 Million	-0.526x	-2.86%
2022-12-31	Skr126.29 Million ≈ $13.59 Million	Skr-64.57 Million ≈ $-6.95 Million	-0.511x	-78.12%
2021-12-31	Skr124.97 Million ≈ $13.45 Million	Skr-35.87 Million ≈ $-3.86 Million	-0.287x	-187.36%
2020-12-31	Skr106.65 Million ≈ $11.48 Million	Skr-10.65 Million ≈ $-1.15 Million	-0.100x	+68.32%
2019-12-31	Skr119.20 Million ≈ $12.83 Million	Skr-37.58 Million ≈ $-4.04 Million	-0.315x	-74.80%
2018-12-31	Skr159.66 Million ≈ $17.18 Million	Skr-28.79 Million ≈ $-3.10 Million	-0.180x	+11.46%
2017-12-31	Skr110.70 Million ≈ $11.91 Million	Skr-22.55 Million ≈ $-2.43 Million	-0.204x	+24.73%
2016-12-31	Skr142.04 Million ≈ $15.29 Million	Skr-38.43 Million ≈ $-4.14 Million	-0.271x	+84.20%
2015-12-31	Skr21.98 Million ≈ $2.37 Million	Skr-37.65 Million ≈ $-4.05 Million	-1.712x	-162.87%
2014-12-31	Skr62.42 Million ≈ $6.72 Million	Skr-40.67 Million ≈ $-4.38 Million	-0.651x	+44.40%
2013-12-31	Skr15.73 Million ≈ $1.69 Million	Skr-18.43 Million ≈ $-1.98 Million	-1.172x	-127.13%
2012-12-31	Skr14.06 Million ≈ $1.51 Million	Skr-7.25 Million ≈ $-780.54K	-0.516x	+64.79%
2011-12-31	Skr3.31 Million ≈ $356.64K	Skr-4.86 Million ≈ $-522.58K	-1.465x	-1395.19%
2009-12-31	Skr-901.48K ≈ $-97.01K	Skr-101.99K ≈ $-10.98K	0.113x	--

About Enzymatica publ AB

ST:ENZY Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$46.89 Million

Skr435.71 Million SEK

Market Cap Rank

#22233 Global

#415 in Sweden

Share Price

Skr1.80

Change (1 day)

-3.49%

52-Week Range

Skr1.65 - Skr3.20

All Time High

Skr770.83